Verified Peptide ReviewLast reviewed: 10 February 2026
Compound Profile · Metabolic
AOD-9604
AOD-9604 is a fragment of human GH originally developed as an obesity therapeutic. Trials produced mixed efficacy results.
LegalResearch onlyEvidenceEmergingHuman useNot approved
7.2/ 10
Peptide Score
Evidence
Safety
Regulatory
Transparency
Quick verdict
Once a promising obesity candidate, now more often discussed in research and supplement contexts than clinical practice.
Reality check
What this isn't
- Not approved for human use — research-only context
- No regulator has approved human use
- Evidence base is early — long-term data limited
- Side-effect profile not fully characterised
- Educational only — not medical advice
Full AOD-9604 review
A 16-amino-acid C-terminal GH fragment.
Looking at alternatives?
Compounds with comparable research interest but different evidence, regulatory status, or risk profile.